P/B
1,2
Daxor
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
$63.3M
Market Cap • 9/11/2026
1971
(55 years)
Founded
1983
(43 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2019,9
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
10,4
EPS
—
Market Cap
Market Cap
63,3M
EV
63,3M
EV/Revenue
2019,9
EV/EBITDA
-33,5
EV/EBIT
-33,5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-13,3%
Total Yield
-13,3%
Dividend Yield 5Y
0%
Payout
0%
Retained Earnings
31,5M
Profitability
Gross Margin
100%
EBITDA Margin
—
EBIT Margin
—
Net Margin
19861,4%
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
0%
% Goodwill
0%
ROE
14,2%
ROIC
—
Growth
CAGR Revenue 5Y
-35%
CAGR Op. Income 5Y
26,2%
CAGR Net Income 5Y
84,1%
CAGR EPS 5Y
3%
CAGR OCF 5Y
27,3%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
2,9
Quick Ratio
0
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!